Life Sciences and Healthcare Companies
Life sciences and healthcare companies face a wide range of unique industry issues that often make them a focus of securities regulators and plaintiffs' firms. These companies can be faced with responding to (i) potential FCPA issues involving public health administrators in foreign countries, (ii) allegations involving disclosures relating to clinical trials and regulatory approvals, (iii) claims of insider trading in advance of positive or negative developments with respect to a new drug candidate, and (iv) cybersecurity issues involving the protection of sensitive health data. Our attorneys have the experience to deal with these and many other securities issues that arise in SEC, DOJ and other governmental investigations, as well as in various types of shareholder litigation. Our clients also benefit from our frequent collaboration with attorneys in the firm's renowned Life Sciences & Healthcare Regulatory practice.
-
Financial Reporting and Other Disclosures: Our attorneys have extensive experience representing life sciences and healthcare companies in governmental investigations, internal investigations and securities litigation involving claims of financial reporting and disclosure issues under the federal securities laws.
-
Insider Trading: Our knowledge of the federal securities laws, relevant caselaw and industry-specific issues enables us to defend life sciences and healthcare companies in insider trading investigations as well as counsel on policies and procedures designed to prevent violations from occurring.
-
Anti-Corruption: With extensive experience around the globe, our attorneys represent life sciences, healthcare and other companies by anticipating and strategically responding to investigations and enforcement actions under the FCPA, UK Bribery Act and other anti-bribery laws and regulations.
Experience Highlights
-
Global pharmaceutical public company in an SEC investigation involving disclosure and related issues.
-
Medical device public company in SEC, DOJ and internal investigations, as well as in related securities litigation, involving financial reporting, disclosure and other issues.
-
Medical device public company in an internal investigation involving accounting, financial reporting, disclosure, and related issues, and defending a related SEC investigation and securities litigation.
-
Large healthcare system in recovering a substantial investment in a money market fund, including filing litigation and assisting the SEC in its investigatory work on the matter.
-
Provider of emergency medical services in shareholder litigation in Delaware Chancery Court involving allegations of breaches of fiduciary duty in connection with an agreement to be acquired by a private equity firm.
-
Subsidiary of a global pharmaceutical public company in a shareholder action in the Supreme Court of New York alleging breach of contract and other claims in connection with a merger agreement.
-
Directors and officers of a health maintenance organization in a securities fraud lawsuit, bankruptcy trustee litigation and state attorney general enforcement action.
-
CEO of a life sciences public company in an SEC investigation, SEC enforcement action, DOJ investigation, internal investigation, securities class action, and shareholder derivative litigation involving the company's restatement and related financial reporting, accounting, disclosure, internal controls, and insider trading issues.
-
President and COO of a healthcare public company in an SEC investigation involving accounting, financial reporting, disclosure, and related issues.
-
General counsel of a medical device public company in an SEC investigation and related SEC litigation involving accounting, financial reporting, disclosure, and related issues.
Key Contacts
Related Services
Recognition
-
U.S. News & World Report and Best Lawyers“Best Law Firms” for Bet-the-Company Litigation—Chicago, Colorado, San Francisco (2024)
"Best Law Firms" for Securities Litigation—Washington, D.C., National (2024)
“Best Law Firms’ for Securities Regulation—Washington, D.C., National (2024)
“Best Law Firms” for Criminal Defense: White Collar—Washington, D.C., National, New Jersey, New York (2024) -
LMG Life Sciences GuideNon-IP Litigation & Enforcement: White-Collar/Government Investigations (2023)
